Convalescent plasma may be a possible treatment for COVID-19: A systematic review

Convalescent plasma(CP) immunotherapy was an effective method for fighting against similar viral infections such as SARS-CoV, and MERS- coV. There is...

Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort

Fluvoxamine strongly binds to the sigma-1 receptor (S1R) that regulates inflammation by inhibiting the production of cytokines, believed to be respons...

Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing Home

Of the 118 residents tested among approximately 130 residents from Facility A during February 28-March 16, 2020, 101 (86%) were found to test positive...

Atypical clinical presentation of COVID-19 infection in residents of a long-term care facility

38 of the 79 residents (48.1%) tested positive for SARS-CoV-2; 48.1% of the residents were negative. Symptoms included cough, diarrhea, fever, hypothe...

SARS-CoV-2 (COVID-19) superspreader events

A significant number of reported COVID-19 cases can be traced back to superspreader events (SSEs) SSEs are events where a large number of secondary ca...

Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response

Canadian cancer centers underwent a rapid and aggressive transformation of services in response to COVID-19. All screening programs across Canada were...

Infection fatality rate of COVID-19 inferred from seroprevalence data

Estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from seroprevalence data. Infection fatality rates ranged from 0.00% to 1....

SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis

In Belgium, the COVID-19 epidemy began on February 4, 2020, with a peak on April 10, 2020. Patients with cystic fibrosis followed in the Cliniques Uni...

Departments

Recent Posts